Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
HPCA encodes the neuronal calcium sensor protein hippocalcin, which is highly expressed in the striatum and critical for calcium-dependent signaling in neurons. Biallelic pathogenic variants in HPCA have been causally linked to autosomal recessive torsion dystonia 2 (PMID:25799108) and broadened to include choreo-dystonia and complex neurodevelopmental phenotypes (PMID:36698997). The disorder is designated as torsion dystonia 2 in the MONDO ontology.
The overall gene–disease relationship is classified as Strong based on 14 probands from 8 unrelated families (PMID:25799108; PMID:36698997), confirmed autosomal recessive segregation in 6 multiplex pedigrees, and concordant functional data demonstrating impaired calcium signaling.
Inheritance is autosomal recessive. Segregation of HPCA variants has been demonstrated in 6 additional affected relatives beyond index cases across multiple families. To date, 14 individuals have harbored biallelic HPCA variants, including nonsense and missense changes; for example, a recurrent novel nonsense variant c.49C>T (p.Arg17Ter) was identified in two unrelated Iranian pedigrees (PMID:36698997). Variant spectrum also includes p.Thr71Asn and p.Ala190Thr, affecting calcium-sensor domains.
Cellular assays have shown that hippocalcin mutants (p.Thr71Asn, p.Asn75Lys, p.Ala190Thr) exhibit defective calcium-dependent oligomerization and altered binding to voltage-gated calcium channels (PMID:28398555). The N75K mutant fails to translocate to the plasma membrane during neuronal activity, disrupting slow afterhyperpolarization and increasing neuronal excitability (PMID:31301343). These findings support a loss-of-function mechanism via perturbed calcium signaling.
No studies to date have refuted the association of HPCA variants with torsion dystonia 2; phenotype variability likely reflects allelic heterogeneity and modifier effects.
Genetic evidence of biallelic HPCA variants in 14 probands, segregation in multiple families, and functional assays demonstrating consistent pathobiology establish a strong clinical validity for HPCA in torsion dystonia 2. This knowledge supports diagnostic sequencing of HPCA in patients with early-onset dystonia or choreo-dystonia and may guide the development of therapies targeting calcium-dependent neuronal pathways.
Key Take-home: HPCA should be included in gene panels for autosomal recessive dystonia given robust genetic and functional evidence of pathogenicity.
Gene–Disease AssociationStrong14 probands across 8 families; segregation in 6 multiplex pedigrees; concordant functional data Genetic EvidenceStrong14 probands with biallelic HPCA variants; autosomal recessive inheritance; variant spectrum includes nonsense and missense changes Functional EvidenceModerateCellular assays demonstrate defective Ca2+-dependent oligomerization and impaired neuronal excitability |